{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T13:35:25Z","timestamp":1655213725245},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.bpobgyn.2008.08.010","type":"journal-article","created":{"date-parts":[[2008,10,2]],"date-time":"2008-10-02T09:31:59Z","timestamp":1222939919000},"page":"1075-1088","source":"Crossref","is-referenced-by-count":11,"title":["Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage"],"prefix":"10.1016","volume":"22","author":[{"given":"E.","family":"Searle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Alfirevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2008.08.010_bib1","series-title":"Obstetric anesthesia: principles and practice","first-page":"17","article-title":"Physiological changes of pregnancy","author":"Conklin","year":"1999"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards a definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib3","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/01.CCM.0000147769.07699.E3","article-title":"Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation","volume":"32","author":"Bakhtiari","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-9560-4-4","article-title":"Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation","volume":"4","author":"Franchini","year":"2006","journal-title":"Thromb J"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2141.2001.02701.x","article-title":"Guidelines for the clinical use of red cell transfusions","volume":"113","author":"British Committee for Standards in Haematology Blood Transfusion Task Force","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib6","series-title":"Guidelines for the blood transfusion services in the United Kingdom","year":"2005"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1423-0410.1998.tb05449.x","article-title":"Replacement of massive blood loss","volume":"74","author":"Hiippala","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/asheducation-2007.1.172","article-title":"Evidence-based platelet transfusion guidelines","author":"Slichter","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.bpobgyn.2008.08.010_bib9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2141.2006.06355.x","article-title":"Guidelines on the management of massive blood loss","volume":"135","author":"British Committee for Standards in Haematology","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1537-2995.2007.01160.x","article-title":"Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice","volume":"47","author":"Johansson","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib11","series-title":"Handbook for transfusion medicine","year":"2007"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.injury.2006.10.003","article-title":"Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients","volume":"38","author":"Maegele","year":"2007","journal-title":"Injury"},{"issue":"1","key":"10.1016\/j.bpobgyn.2008.08.010_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.TA.0000075338.21177.EF","article-title":"Early coagulopathy predicts mortality in trauma","volume":"55","author":"MacLeod","year":"2003","journal-title":"J Trauma"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib14","doi-asserted-by":"crossref","unstructured":"Stanworth SJ. The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology Am Soc Hematol Educ Program 2007; 2007: 179\u2013186.","DOI":"10.1182\/asheducation-2007.1.179"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/TA.0b013e3181271ba3","article-title":"The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital","volume":"63","author":"Borgman","year":"2007","journal-title":"J Trauma"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.mbc.0000061298.28953.7d","article-title":"Coagulation factor content of solvent\/detergent plasma compared with fresh frozen plasma","volume":"14","author":"Doyle","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1537-2995.1999.39111227.x","article-title":"A randomized trial of solvent\/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation","volume":"39","author":"Williamson","year":"1999","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.bpobgyn.2008.08.010_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/j.jvca.2006.09.002","article-title":"Fatal fibrinolysis during orthotopic liver transplantation in patients receiving solvent\/detergent-treated plasma (Octaplas)","volume":"21","author":"Magner","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"2","key":"10.1016\/j.bpobgyn.2008.08.010_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"The decrease in fibrinogen is an early predictor of the severity of postpartum haemorrhage","volume":"5","author":"Charbit","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2004.08.003","article-title":"Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency","volume":"32","author":"Kreuz","year":"2005","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.bpobgyn.2008.08.010_bib21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1213\/ane.0b013e318163fb26","article-title":"Fibrinogen in craniosynostosis surgery","volume":"106","author":"Haas","year":"2008","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.bpobgyn.2008.08.010_bib22","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1537-2995.2007.01404.x","article-title":"How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol","volume":"47","author":"Burtelow","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib23","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1471-0528.1996.tb09638.x","article-title":"Tranexamic acid in the management of postpartum haemorrhage","volume":"103","author":"As","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2008.08.010_bib24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1034\/j.1600-0412.2001.080005409.x","article-title":"Peripartum hysterectomy-incidence and maternal morbidity","volume":"80","author":"B\u00f8e Engelsen","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"Mannucci","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2044.1993.tb07014.x","article-title":"Reduction of acute haemorrhage with aprotinin","volume":"48","author":"Valentine","year":"1993","journal-title":"Anaesthesia"},{"issue":"3","key":"10.1016\/j.bpobgyn.2008.08.010_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001721-199008000-00009","article-title":"Factor VIIa in the treatment of haemophilia","volume":"1","author":"Hedner","year":"1990","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib28","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/01.AOG.0000288515.48066.99","article-title":"Use of recombinant activated factor VII in primary postpartum hemorrhage: the northern European registry 2000\u20132004","volume":"110","author":"Alfirevic","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"9353","key":"10.1016\/j.bpobgyn.2008.08.010_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(03)12268-4","article-title":"Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial","volume":"361","author":"Friederich","year":"2003","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.bpobgyn.2008.08.010_bib30","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/BRS.0b013e3181557d45","article-title":"Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial","volume":"32","author":"Sachs","year":"2007","journal-title":"Spine"},{"issue":"6","key":"10.1016\/j.bpobgyn.2008.08.010_bib31","doi-asserted-by":"crossref","first-page":"R178","DOI":"10.1186\/cc5133","article-title":"Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials","volume":"10","author":"Rizoli","year":"2006","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.bpobgyn.2008.08.010_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1017\/S0265021507003109","article-title":"Use of recombinant factor VIIa in massive post-partum haemorrhage","volume":"25","author":"McMorrow","year":"2008","journal-title":"Eur J Anaesthesiol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2008.08.010_bib33","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1399-6576.2007.01323.x","article-title":"An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage","volume":"51","author":"Ahonen","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bpobgyn.2008.08.010_bib34","first-page":"1","article-title":"Use of recombinant activated factor VII for massive postpartum hemorrhage","author":"Hossain","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.bpobgyn.2008.08.010_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1586\/17474108.2.2.217","article-title":"Overview on the use of recombinant factor VIIa in obstetrics and gynecology","volume":"2","author":"Scarpelini","year":"2007","journal-title":"Exp Rev Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2008.08.010_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1471-0528.2006.01156.x","article-title":"The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage","volume":"114","author":"Franchini","year":"2007","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.bpobgyn.2008.08.010_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1445-5994.2007.01472.x","article-title":"Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register","volume":"38","author":"Isbister","year":"2008","journal-title":"Intern Med J"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693408001065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693408001065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:11:37Z","timestamp":1557832297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693408001065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1521693408001065"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2008.08.010","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}